We are live on ! Find out more
FLAC

Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares
FLAC

Delisted

FLAC was delisted on the 22nd of November, 2022.

Back to rankings

0 hedge funds and large institutions have $0 invested in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 52 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 52 → 0 (-52)

100% less capital invested

Capital invested by funds: $102M → $0 (-$102M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 52

Holders
–
Holders Change
-52
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
52
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
GCL
Glazer Capital LLC
New York
-$13.6M
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$7.05M
3
Millennium Management
Millennium Management
New York
-$6.69M
4
Goldman Sachs
Goldman Sachs
New York
-$4.96M
5
EC
EcoR1 Capital
California
-$4.86M

FLAC Hedge Fund Activity: Q4 2022 in Review

0 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) for Q4 2022, worth a combined $0 — down 100% from $102M a quarter earlier.

Sellers outnumbered buyers: 52 funds closed out of FLAC and 0 opened new positions — a net loss of 52 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Glazer Capital LLC, exiting entirely with an estimated $13.6M sold.

  • 0 institutional investors held Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) as of Q4 2022, down from 52 in Q3 2022.
  • Funds reported $0 of Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares stock for Q4 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares positions in Q4 2022 and 52 closed out, a net change of -52 holders.
  • The largest Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares seller in Q4 2022 was Glazer Capital LLC, an estimated $13.6M sold.

Based on aggregated 13F filings for Q4 2022.